Abstract
Successful vaccination policies for protection from invasive pneumococcal diseases (IPD) dependent on determination of the exact serotype distribution in each country. We aimed to identify serotypes of pneumococcal strains causing IPD in children in Turkey and emphasize the change in the serotypes before and after vaccination with 7-valent pneumococcal conjugate vaccine (PCV-7) was included and PCV-13 was newly changed in Turkish National Immunization Program. Streptococcus pneumoniae strains were isolated at 22 different hospitals of Turkey, which provide healthcare services to approximately 65% of the Turkish population. Of the 335 diagnosed cases with S. pneumoniae over the whole period of 2008-2014, the most common vaccine serotypes were 19F (15.8%), 6B (5.9%), 14 (5.9%), and 3 (5.9%). During the first 5 years of age, which is the target population for vaccination, the potential serotype coverage ranged from 57.5 % to 36.8%, from 65.0% to 44.7%, and from 77.4% to 60.5% for PCV-7, PCV-10, and PCV-13 in 2008-2014, respectively. The ratio of non-vaccine serotypes was 27.2% in 2008-2010 whereas was 37.6% in 2011-2014 (p=0.045). S. penumoniae serotypes was less non-susceptible to penicillin as compared to our previous results (3...Continue Reading
References
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R Feikin, Keith P Klugman
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R FeikinUNKNOWN Active Bacterial Core surveillance/Emerging Infections Program Network
Apr 7, 2006·The New England Journal of Medicine·Moe H KyawUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Apr 8, 2006·European Journal of Pediatrics·Isik YalçinBülent Yildirim
Apr 2, 2008·International Journal of Antimicrobial Agents·Mathias W PletzHartmut Lode
Oct 31, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael R JacobsAnne R Windau
Jun 24, 2009·Vaccine·Ron Dagan
Jul 17, 2009·International Journal of Medical Microbiology : IJMM·Matthias ImöhlMark van der Linden
Aug 25, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Daniel J IsaacmanRalf R Reinert
Jan 21, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M CeyhanR C George
Oct 20, 2010·PLoS Medicine·Hope L JohnsonKatherine L O'Brien
Apr 16, 2011·Lancet·Daniel M WeinbergerMarc Lipsitch
Apr 22, 2011·Clinical and Vaccine Immunology : CVI·Mehmet CeyhanAhmet Kizirgil
Sep 4, 2012·Vaccine·S Ben-ShimolUNKNOWN Israeli Bacteremia and Meningitis Active Surveillance Group
Sep 8, 2012·BMC Infectious Diseases·Catherine Weil-OlivierLorenzo Mantovani
May 3, 2013·Clinical and Vaccine Immunology : CVI·Mehmet CeyhanAslinur Ozkaya Parlakay
Oct 3, 2013·PLoS Medicine·Daniel R FeikinUNKNOWN Serotype Replacement Study Group
Apr 3, 2014·Vaccine·Shalom Ben-ShimolRon Dagan
May 6, 2014·Vaccine·Adoración Navarro TornéUNKNOWN ECDC country experts for pneumococcal disease
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Wanatpreeya PhongsamartKulkanya Chokephaibulkit
Dec 3, 2014·Vaccine·A LepoutreUNKNOWN ORP Networks
Dec 6, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A SkoczyńskaUNKNOWN Participants of a laboratory-based surveillance of community acquired invasive bacterial infections (BINet)
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Mehmet CeyhanYavuz Coşkun
Jan 24, 2015·Vaccine·Gili Regev-YochayUNKNOWN IAIPD group
Citations
Mar 15, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·X ZhouY Liu
Apr 21, 2016·Human Vaccines & Immunotherapeutics·Mehmet CeyhanLyazzat Yeraliyeva
Dec 3, 2016·Human Vaccines & Immunotherapeutics·Sevgen Tanır BasaranogluMehmet Ceyhan
Apr 15, 2017·Expert Review of Vaccines·Robert CohenCorinne Levy
Jun 3, 2017·Human Vaccines & Immunotherapeutics·Ayşe BüyükcamMehmet Ceyhan
Jun 13, 2020·Human Vaccines & Immunotherapeutics·Mehmet CeyhanYasemin Ay Altintop
Jul 28, 2019·Human Vaccines & Immunotherapeutics·B GülhanA Ozkaya-Parlakay
Oct 5, 2019·Expert Review of Vaccines·Myint Tin Tin HtarLuis Jodar
Sep 3, 2020·European Journal of Pediatrics·Rumeysa YalçinkayaMehmet Ceyhan
Apr 21, 2020·Infectious Disorders Drug Targets·Abdollah KarimiSedigheh Rafiei Tabatabaei